The FTSE 100 index in London pushed through the 6,000 mark earlier but closed below it, with gains led by support services stocks
Archive for May, 2011
Footsie closes higher on new Greek optimism
Tuesday, May 31st, 2011Colonel we shrank your cash pile, have some stock
Tuesday, May 31st, 2011The Wall Street Journal has revealed how Goldman Sachs offered preferred stock to Colonel Gaddafi-controlled fund
Euro leaders in move to let Greece cut VAT rate to appease opposition
Tuesday, May 31st, 2011• Athens prepares for vital decision on second bailout
• Opposition demands tax moves to re-start economy
BlackRock attacks investment banks over float valuations
Monday, May 30th, 2011• London market’s biggest institutional investor writes letter to bankers
• Short-term incentive fees ‘seem to drive aggressive behaviour’
British Chambers of Commerce raises new fears for UK growth
Monday, May 30th, 2011Business lobby group casts doubt over official UK growth estimates but still supports government plans to reduce deficit
Tunisia and Egypt promised G8 help on path to democracy
Friday, May 27th, 2011G8 leaders support Arab spring goals by pledging £20bn in loans and aid to Middle East countries
Builders lifted by Nationwide price figures, while banks boost FTSE 100
Friday, May 27th, 2011Ahead of yet another long weekend the market is moving higher, but in very thin trading, with housebuilders among the main gainers
Banks and miners lead FTSE 100 higher ahead of holiday weekend
Friday, May 27th, 2011Petropavlovsk, the Russian gold group formerly known in more simple times as Peter Hambro Mining, has been the subject of much speculation in recent days, from talk that the company was contemplating a fundraising to it being a takeover target
Exchange-traded funds ‘need more transparency’
Friday, May 27th, 2011An investment chief executive says exchange-traded funds can diverge markedly from what some investors would expect, and calls for more information on potential risks
Banks lead FTSE 100 higher but Shire slips on competition concerns
Wednesday, May 25th, 2011Shire is facing a growing number of challenges to one of its best selling drugs, sending its shares lower in a rising market